Brief: JCR Pharmaceuticals Co Ltd Announces Research Collaboration, Option And License Agreement With Alexion On Discovery Of Oligonucleotide Therapeutics Using J-Brain Cargo
20/12/2023 07:04
Dec 20 (Reuters) - JCR Pharmaceuticals Co Ltd 4552.T :
* JCR PHARMACEUTICALS CO LTD ANNOUNCES RESEARCH COLLABORATION, OPTION AND
LICENSE
AGREEMENT WITH ALEXION ON DISCOVERY OF OLIGONUCLEOTIDE THERAPEUTICS USING
J-BRAIN CARGO
Source text for Eikon: ID:nTSxt7b8c8
Further company coverage: 4552.T
Recent news on JCR Pharmaceuticals
See all newsBrief: JCR Pharmaceuticals Receives Marketing Authorization In Kuwait For Izcargo
Italfarmaco And Jcr Pharmaceuticals Enter Into Exclusive License Agreement For Jr-141 In United States, Europe, And Latin America
Brief: Jcr Pharmaceuticals Receives Orphan Drug Designation For Givinostat In Japan
Brief: Medipal & JCR Dose First Patient In Global Phase I/II Trial OF JR-446 For Mucopolysaccharidosis Type IIIB
Table: Jcr Pharmaceuticals -Q1 group results